Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab

Detalles Bibliográficos
Autores principales: Demoulin, Nathalie, Scohy, Anaïs, Gillion, Valentine, Godefroid, Nathalie, Jadoul, Michel, Morelle, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344438/
https://www.ncbi.nlm.nih.gov/pubmed/34471526
http://dx.doi.org/10.1093/ckj/sfab102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344438/
https://www.ncbi.nlm.nih.gov/pubmed/34471526
http://dx.doi.org/10.1093/ckj/sfab102

Ejemplares similares